Brenda Tejeda, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 140 Brimley Dr, Fredericksbrg, VA 22406 Phone: 540-752-0111 |
News Archive
Abbott has completed its acquisition of Facet Biotech Corporation, strengthening its pharmaceutical pipeline in immunology and oncology.
When the revolutionary Echo® acoustic liquid handler is used in the process of discovering potential therapeutics, important drug candidates are identified that are missed using traditional liquid handlers. In a recently issued patent, the global pharmaceutical company AstraZeneca describes the discovery of a novel set of potential cancer therapeutics that was found only when the Echo system was used. Other major pharmaceutical companies have also reported that the Echo liquid handler was a critical platform in discovering drug candidates.
A new study from The University of Texas Medical Branch at Galveston of more than 30,000 commercially insured men is the first large comparative analysis to show that there is no link between testosterone therapy and blood clots in veins. The study found that middle-aged and older men who receive testosterone therapy are not at increased risk of this illness.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 16th Annual Connective Tissue Oncology Society (CTOS) Meeting taking place in Paris, France from November 11 to 13, 2010.
"Jim Yong Kim, the U.S. nominee, seems certain to become the next president of the World Bank after developing countries failed in an effort to unite behind a single candidate," the Financial Times reports, noting, "Jose Antonio Ocampo, the former Colombian finance minister, withdrew from contention and endorsed Ngozi Okonjo-Iweala, the Nigerian finance minister, after she won wider support among a group of developing countries on Friday."
› Verified 9 days ago